UK MHRA makes progress on new track & trace system for high-risk devices
This article was originally published in SRA
The UK Medicines and Healthcare products Regulatory Agency is developing a new system that can track the performance of high-risk medical devices and trace patients in the event of a device recall or safety alert, without the need for multiple device registries1.
You may also be interested in...
The International Pharmaceutical Regulators Programme has documented various approaches currently being used for the clinical comparability of biosimilar monoclonal antibodies in different jurisdictions.
Remote inspections are here to stay, and global regulators are aligning efforts to develop consensus on how these should be conducted.
Device companies operating in Canada are being advised to review their internal procedures in anticipation of new postmarket requirements that come into force this year.